Hyperosmolar Hyperglycemic State (HHS)

Hyperosmolar Hyperglycemic State (HHS) is a critical, life-threatening complication of diabetes, most commonly associated with Type 2 Diabetes Mellitus. It occurs when blood glucose levels rise dramatically, often exceeding 600 mg/dL, leading to severe dehydration and increased plasma osmolarity. Unlike Diabetic Ketoacidosis (DKA), HHS typically does not involve significant ketone production, but its consequences can be equally dangerous.

The condition develops gradually, often triggered by infections, missed medications, or other illnesses. Symptoms include extreme thirst, frequent urination, profound weakness, confusion, seizures, and in severe cases, coma. Because of its insidious onset, HHS is frequently diagnosed late, increasing the risk of complications such as organ failure.

Diagnosis relies on laboratory findings of very high blood glucose, elevated serum osmolarity, and absence of significant ketoacidosis. Immediate treatment is essential and involves intravenous fluids to correct dehydration, insulin therapy to reduce blood sugar, and electrolyte replacement to restore balance. Hospitalization is almost always required to stabilize patients.

Prevention focuses on consistent diabetes management, adherence to prescribed medications, and early recognition of warning signs. Education about monitoring blood glucose during illness and maintaining hydration is crucial. With timely intervention, recovery is possible, but delayed treatment can be fatal.